ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). In Onkológia, 2018, roč. 13, č. 1, s. 73. ISSN 1336-8176. Bratislava : SOLEN, 2018.